Local failure patterns after radical resection and adjuvant chemotherapy in patients with pN2 nonsmall-cell lung cancer: A retrospective analysis

被引:3
|
作者
Wang, Chenyu [1 ]
Li, Haixia [1 ]
Chen, Yongshun [2 ]
Ge, Hong [1 ]
机构
[1] Zhengzhou Univ, Affiliated Canc Hosp, Dept Radiat Oncol, Zhengzhou, Peoples R China
[2] Wuhan Univ, Renmin Hosp, Dept Oncol, Wuhan, Peoples R China
关键词
Nodal recurrence; nonsmall cell lung cancer; pN2; postoperative radiotherapy; VINORELBINE PLUS CISPLATIN; POSTOPERATIVE RADIOTHERAPY; TARGET VOLUME; STAGE-I; THERAPY; SURVIVAL;
D O I
10.4103/ijc.IJC_691_18
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The patterns of local failure in stage pN2 nonsmall-cell lung cancer (NSCLC) patients undergoing radical resection and adjuvant chemotherapy are controversial. Methods: The sites of local failure were compared in subgroups of patients with relevant clinicopathologic features (e.g., location and size of primary lesions). Results: Totally 75 patients with local failure after radical resection and adjuvant chemotherapy for pN2 NSCLC were included in the analysis. Thirty-seven (49.3%) patients had distant metastasis. The median duration from surgical resection to local failure was 11 months (range: 3-45 months). Sites with >= 10% failure rate in all subgroups based on the location of the primary lesions included 4R, 7, the ipsilateral hilum, and the stump. Additional sites with >= 10% failure rate included 2R, 2L, 4L, and 5 for lesions in the left upper lobe; 4L and 5 for lesions in the left lower lobe; and 2R and 3P for lesions in the right upper-middle lobe. Squamous cell carcinoma affected the stump failure rate compared to adenocarcinoma (56.3% vs. 18.0%, P = 0.003). Tumor diameter >= 5 cm affected the stump failure rate compared to tumor diameter < 5 cm (44.0% vs. 18.0%, P = 0.016). Skip N2 metastasis affected the ipsilateral hilum failure rate compared to nonskip N2 metastasis (7.5% vs. 31.4%, P = 0.008) Conclusions: For pN2 NSCLC patients undergoing radical resection and adjuvant chemotherapy, different lung lobes had different high-risk failure sites. Left lung cancer is prone to bilateral mediastinal lymph nodes recurrence, while right lung cancer mainly recurs with ipsilateral mediastinal lymph nodes. Moreover, the local failure patterns are influenced by pathological type, tumor size, and skip N2 metastasis.
引用
收藏
页码:323 / 329
页数:7
相关论文
共 50 条
  • [31] Clinical courses of patients with small cell lung cancer after complete resection followed by adjuvant chemotherapy
    Shinno, Y.
    Kanda, S.
    Sato, J.
    Morita, R.
    Matsumoto, Y.
    Murakami, S.
    Goto, Y.
    Horinouchi, H.
    Fujiwara, Y.
    Yamamoto, N.
    Ohe, Y.
    ANNALS OF ONCOLOGY, 2018, 29
  • [32] Patterns of relapse of N2 nonsmall-cell lung carcinoma patients treated with preoperative chemotherapy Should prophylactic cranial irradiation be reconsidered?
    Andre, F
    Grunenwald, D
    Pujol, JL
    Girard, P
    Dujon, A
    Brouchet, L
    Brichon, PY
    Westeel, V
    Le Chevalier, T
    CANCER, 2001, 91 (12) : 2394 - 2400
  • [33] Exploring the Impact of Age on the Efficacy of Adjuvant Chemotherapy After Radical Resection in Non-Small Cell Lung Cancer
    Davidson, C.
    Taylor, K.
    Scullin, P.
    Campbell, L.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S855 - S855
  • [34] Cost Analysis of a Randomized Trial of Early Palliative Care in Patients with Metastatic Nonsmall-Cell Lung Cancer
    Greer, Joseph A.
    Tramontano, Angela C.
    McMahon, Pamela M.
    Pirl, William F.
    Jackson, Vicki A.
    El-Jawahri, Areej
    Parikh, Ravi B.
    Muzikansky, Alona
    Gallagher, Emily R.
    Temel, Jennifer S.
    JOURNAL OF PALLIATIVE MEDICINE, 2016, 19 (08) : 842 - 848
  • [35] Survival after Surgery for pN1 and pN2 Small Cell Lung Cancer: A Comparison with Surgical Treatment of Non-Small Cell Lung Cancer
    Yang, Chi-Fu J.
    Chan, Derek Y.
    Gulack, Brian C.
    Speicher, Paul J.
    Hartwig, Matthew G.
    Berry, Mark F.
    Tong, Betty C.
    Onaitis, Mark W.
    D'Amico, Thomas A.
    Harpole, David
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S399 - S400
  • [36] Is major pathologic response sufficient to predict survival in resectable nonsmall-cell lung cancer patients receiving neoadjuvant chemotherapy?
    Cai, Jing-Sheng
    Li, Shuo
    Yan, Shu-Mei
    Yang, Jie
    Yang, Mu-Zi
    Xie, Chu-Long
    Li, Ji-Bin
    Feng, Yan-Fen
    Yang, Hao-Xian
    Hou, Xue
    THORACIC CANCER, 2021, 12 (09) : 1336 - 1346
  • [37] Postoperative Radiotherapy can Improve the Disease-Free Survival of EGFR Wild Type Patients with pN2 NSCLC after Complete Resection and Adjuvant Chemotherapy
    Liu, Y.
    Yang, X.
    Men, Y.
    Sun, S.
    Yuan, M.
    Bao, Y.
    Ma, Z.
    Zhai, Y. R.
    Wang, J.
    Deng, L.
    Wang, W.
    Bi, N.
    Wang, L.
    Hui, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E380 - E380
  • [38] Adjuvant chemotherapy after complete resection in non-small-cell lung cancer
    Wada, H
    Hitomi, S
    Teramatsu, T
    Ikeda, S
    Okada, Y
    Kusakawa, M
    Soejima, R
    Teramoto, S
    Tomita, M
    Hirakawa, A
    Maeda, M
    Yamamoto, K
    Monden, Y
    Kimura, I
    Ohta, M
    Ayabe, H
    Ito, M
    Kato, H
    Genka, K
    Shimizu, N
    Tsubota, N
    Nakamoto, K
    Namikawa, S
    Matsubara, Y
    Okimoto, J
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (04) : 1048 - 1054
  • [39] Adjuvant Chemotherapy After Complete Resection of Non-Small Cell Lung Cancer
    Laack, E.
    Bokemeyer, C.
    Hossfeld, D. K.
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2008, 105 (14): : 249 - 254
  • [40] DOES ADJUVANT CHEMOTHERAPY DECREASE DISTANT METASTASIS FORMATION IN PATIENTS WITH NONSMALL CELL LUNG-CANCER
    GREEN, MR
    LUNG CANCER, 1994, 10 : S187 - S194